Servier Pharmaceuticals shared on LinkedIn:
“For people living with rare diseases, every day matters.
That’s why Servier hosted Pioneering the Path for Rare Diseases: A Transatlantic Policy and Innovation Summit – bringing together global leaders across research, policy, regulatory, and patient advocacy to discuss how we can remove barriers that slow access to innovative treatments.
By fostering transatlantic collaboration and elevating hashtag#patient voices, we’re working toward a future where scientific breakthroughs reach patients faster.
Other articles about Servier on OncoDaily.